(19)
(11) EP 4 522 117 A1

(12)

(43) Date of publication:
19.03.2025 Bulletin 2025/12

(21) Application number: 23729902.9

(22) Date of filing: 11.05.2023
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 9/51(2006.01)
 A61K 9/48(2006.01)
A61K 39/395(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/5138; A61K 9/5161; A61K 9/5192; A61K 9/0053; A61K 9/4866; A61K 9/4891; C07K 2317/23; C07K 16/00; C07K 2317/52
(86) International application number:
PCT/US2023/021842
(87) International publication number:
WO 2023/220243 (16.11.2023 Gazette 2023/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 13.05.2022 US 202263341727 P

(71) Applicant: Prodigy Biotech, Inc.
West Chester, PA 19382 (US)

(72) Inventors:
  • GUPTA, Vivek
    NY 11001 (US)
  • PARVATHANENI, Vineela
    Queens, NY 11439 (US)
  • SARVEPALLI, Sruthi
    Queens, NY 11439 (US)

(74) Representative: Haseltine Lake Kempner LLP 
One Portwall Square Portwall Lane
Bristol BS1 6BH
Bristol BS1 6BH (GB)

   


(54) FORMULATIONS FOR ORAL DELIVERY OF POLYPEPTIDES, ANTIBODIES AND PROTEINS AND USES THEREOF